Sestrin2 upregulation was shown to accelerate autophagic Keap1 degradation and improve Nrf2-mediated antioxidant response in a rat model of diabetic nephropathy and murine podocyte cell line exposed to high glucose concentration [100]. This evidence concerns the gene NFE2L2 and diabetic kidney disease.